Care.Know.Do Pilot: Version 1
Research type
Research Study
Full title
Pilot evaluation of Care.Know.Do: a self-management intervention to support patients with chronic kidney disease.
IRAS ID
184206
Contact name
John Weinman
Contact email
Sponsor organisation
Atlantis Healthcare
Duration of Study in the UK
1 years, 6 months, days
Research summary
Research suggests that factors such as depression, lack of understanding of the relationship between high blood pressure, cardiovascular disease and kidney function, poor healthcare provider--patient communication and lack of social support can impact negatively on medication adherence and lifestyle modification in patients with CKD. Care.Know.Do aims to support CKD patients with these issues to achieve improved outcomes through improving self-management behaviours. This tailored, online patient support programme includes supplementary telephone calls and email/SMS messages, to support patients with CKD from the beginning of secondary care. The Care.Know.Do website will be integrated with (Renal) Patient View, a portal which gives patients direct access to their clinic test results. Care.Know.Do will pull key clinical data from Patient View, namely BP, eGFR, albumin:creatnine ration (ACR), and HbA1c to assess the Care.KnowDo’s impact on these clinical measures. Patients enrolling onto the programme will be asked to complete a screening questionnaire, so that the type of support they receive through the interventional channels can be tailored to their specific needs. The online programme includes three key modules to address: low mood (Mind Matters), lifestyle (Lifestyle Matters) and adherence to hypertension medication (Medication Matters). The aim of this exploratory study is to estimate the size of effect of the intervention and determine in which patient group this is the most significant, as well as test acceptability to patient and estimate ease of setting up and running a larger definitive trial. In addition to the screening questionnaire, patients will be asked to complete two follow up questionnaires to evaluate the effectiveness of the programme on patients self-management behaviours, their psychosocial well-being and illness/ treatment perceptions. A select group of patients and healthcare practioners will also be asked to participate in a qualitative interview to assess programme acceptability.
REC name
London - Dulwich Research Ethics Committee
REC reference
15/LO/1700
Date of REC Opinion
14 Dec 2015
REC opinion
Further Information Favourable Opinion